Why Jefferies Hit the Brakes on the Top Performing Dow Stock
Jefferies is downgrading Verizon Communications to a Hold rating but maintaining a $53 price target, citing elusive growth and strategic uncertainty.
All Work
Chris Lange
Ionis Stumbles on FDA Clinical Hold
Ionis Pharmaceuticals made waves in the market on Thursday following a business update on its IONIS-TTR program.
Aeglea BioTherapeutics Enters the Market Way Below Expected Price Range
Aeglea BioTherapeutics entered the market quietly on Thursday morning, with pricing below the expected range of $16 to $18 per share.
JD Power Survey Finds Charles Schwab Best in Investor Satisfaction
J.D. Power’s Full Service Investor Satisfaction Study highlighted how a steadily increasing number of investment advisory customers have disrupted conventional thinking about full-service and self-directed advisory services.
Jobless Claims Hover Near Record Lows
Currently, jobless claims are holding at record lows, indicating a lack of layoffs and ongoing strength for the nation's labor market.
Rite Aid Posts Solid Q4 Earnings
Rite Aid released mixed fiscal fourth-quarter earnings report before the markets opened on Thursday.
CarMax Falls Despite Top-Line Beat
CarMax reported its fiscal fourth-quarter financial results before the markets opened on Thursday.
Jefferies Sees 2 Top Auto Financial Stocks With Most Upside
Jefferies notes in its most recent report that the macroeconomic backdrop remains somewhat supportive in terms of new and used car sales, gas prices and a generally improving economy.
Bed Bath & Beyond Rises on Earnings Beat and Brand New Dividend
Bed Bath & Beyond Inc. (NASDAQ: BBBY) reported its fiscal fourth-quarter financial results after the markets closed on Wednesday. The company had $1.91 in earnings per share (EPS) on $3.4 billion in revenue compared…
What to Look for in CarMax Earnings
CarMax is scheduled to release its fiscal fourth-quarter financial results before the markets open on Thursday.
What to Expect From Rite Aid Earnings
Rite Aid is scheduled to report its fiscal fourth-quarter financial results before the markets open on Thursday.
Halliburton and Baker Hughes Plan to Fight Justice Department Lawsuit
Halliburton and Baker Hughes are taking a stand against the U.S. Department of Justice's most recent effort to block their intended merger.
Why Sangamo Shares Could More Than Double
Janney Montgomery Scott reiterated its Buy rating and $15 fair value estimate on Sangamo Biosciences as it brings multiple programs to the clinic this year.
Why Goldman Sachs Sees Good News Being Bad for Stocks
The global tactical equity idea generation team examined the relationship between the S&P 500 and the Goldman Sachs Research's Surprise Index, which compares economic data releases with consensus expectations.
5 Biotechs With the Most Upside This Earnings Cycle
Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help sentiment continue to turn around.
Monsanto Falls Short on Earnings but Lifts Guidance
Monsanto reported disappointing fiscal second-quarter financial results before the markets opened Wednesday.
What to Look for in Monsanto Earnings
Monsanto Co. (NYSE: MON) is set to share its latest quarterly earnings before the markets open on Wednesday. The consensus estimates from Thomson Reuters call for $2.44 in earnings per share (EPS) and $4.76…
Marvell Soars Despite Senior Leadership Stepping Down
Marvell Technology Group watched its shares jump in Tuesday’s regular trading session following an announced transition in senior leadership.
SEC Charges 4 With Fraud in ‘Free Dinner’
The SEC recently announced that it has charged four individuals in a fraud in which victims included seniors who were solicited at "free dinner" investment seminars in Florida.
What to Expect From Bed Bath & Beyond Earnings
Bed Bath & Beyond is scheduled to report its fiscal fourth-quarter financial results after the markets close on Wednesday.